Ivera Medical Corporation v. Hospira, Inc., No. 14-1613 (Fed. Cir. Sept. 8, 2015)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Ivera Medical Corp. (“Ivera”) sued Hospir a, Inc. (“Hospira”) in the Southern District of California alleging infringement of U.S. Patent Nos. 7,780,794 (the ’794 patent), 7,985,302 (the ’302 patent), and 8,206,514 (the ’514 patent). The district court grant ed summary jud g- ment of invalidity , finding the asserted patent claims obvious under 35 U.S.C. § 103. Ivera appeals. For the reasons that follow, we reverse and remand. BACKGROUND A. The Patents-in-Suit.